🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A must-read Review on the ever-evolving field of #EGFR mut #NSCLC in@NatRevClinOncol highlighting: ➡️Strategies to improve on 1L 3rd Gen TKI mono therapy ➡️ Ways to tackle resistance post-Osi ➡️Perioperative landscape Xiuning Le MD PhD Daniel Tan Suresh S. Ramalingam, MD, FASCO IASLC #LCSM #some

One of the best things we have done at the #FlorezLab has been the #HearHer campaign to increase awareness about lung cancer in women ❤️

I am excited to share a blog I wrote for CURE Today highlighting the #LungCancerGeneticsStudy—a collaboration between the #lungcancer community and 23andMe to find the genetic risks of lung cancer. My kids are my personal why but the study represents something bigger:

We were just notified all NIH nickCTEP_ClinRes @NCI meetings are now CANCELLED. Investigators PLS continue your hard work and dedication to make a difference. #Cancer is indifferent to politics and impacts everyone. @asco #ASCOGI25 #CancerResearch science.org/content/articl…

Grateful to work with these incredible women!!

The Florez Lab is hiring! Regulatory specialist and research data specialist for our New Clinical and Research Young Lung Cancer Program at Dana-Farber Cancer Institute Job posting here: careers.dana-farber.org/job/11220/rese… Please apply directly, no DMs.

Now we wait for Friday!

What a day—found out I matched and was selected as a Massachusetts Medical Society 2025 Scholar! Incredibly grateful for the support and mentorship that got me where I am today. I am going to be a doctor!!

The sweetest gift from my ladies at #FlorezLab to celebrate my match! Grateful to be surrounded by brilliant women who inspire me each day to break down barriers in cancer care. Narjust Florez, MD, FASCO #GreatWomenOfScience

With some many conversations about lung cancer in young women, I invite you revisit our editorial in ASCO Connections early this year where we discussed the #HearHer campaign connection.asco.org/do/hearher-cam…

Getting great questions from patients with EGFR+ lung cancer about the #MARIPOSA and #MARIPOSA2 studies after #ELCC25, and how they differ. What else should we add to this table to make it more helpful? EGFR Resisters Jill Feldman

We’re recruiting! If you’re East Asian or Latinx and between 40–80 years old, you may be eligible to join our study on early lung cancer screening. Reach out to learn more. #equalstudy

🎉 Big news our #equalstudy is officially OPEN! 🧬 Hear from our ctDNA Program Manager, Courtney Mantz, as she introduces this groundbreaking study using a simple blood test to possibly detect EGFR+ lung cancer. 👥 Are you 40+ and identify as Hispanic/Latinx or East/Southeast

📢 Meet Dr. Florez Narjust Florez, MD, FASCO, the Principal Investigator of the #EQUALstudy, as she shares more about this exciting research EN ESPAÑOL✨ #latinasinmed 🧬 This study uses a blood test to help detect EGFR+ lung cancer and we’re proud to offer participation in this study

The #EQUAL Study: "EGFR CtDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations" is open to enrollment! Learn more about it here: ⏬️⏬️ clinicaltrials.gov/study/NCT06716… #FlorezLab Narjust Florez, MD, FASCO lilin Tong Dana-Farber News